When to Move to 5mg Mounjaro: How to Judge the Right Time

Why the 2.5mg dose isn't the whole story

If you feel like nothing is happening on 2.5mg, you are almost certainly right, and that is by design. The first pen's job is to prepare your digestive system for a medicine that works partly by slowing how quickly your stomach empties. Starting gently reduces the intensity of nausea, vomiting and other gastrointestinal effects that many people experience in the early weeks. A lot of people find the four-week wait frustrating, particularly when they started Mounjaro hoping to see quick change. That feeling is completely understandable.

The NHS patient information for tirzepatide confirms the standard titration pattern: four weeks at each dose level before moving to the next, subject to how you are tolerating the current one. Your prescriber follows this licensed schedule, which runs from 2.5mg up through 5, 7.5, 10, 12.5 and 15mg. If you are weighing up when to go up to 5mg on Mounjaro, knowing that this is the first step where most people begin to notice a meaningful appetite change is a useful place to start.

Understanding this framing matters when you are deciding whether to ask about moving up. You are not behind if you are still at 2.5mg after four weeks; you are at the scheduled point. The full Mounjaro overview covers how the dual GIP and GLP-1 mechanism works across the dose range, if you want more background before your next review.

Signals that suggest you are ready for 5mg

There is no single test that says you are ready. Instead, prescribers look at a cluster of signs, and readiness is really the absence of reasons to wait. The clearest signal is tolerating 2.5mg without significant disruption: you have completed the four weeks, side effects have either not appeared or have settled to a manageable level, and your daily life has not been derailed. That pattern tells a prescriber your system has adapted.

Appetite suppression at 2.5mg varies enormously between people. Some patients notice a real reduction in hunger from the first week; others notice very little and feel impatient for the dose to do more. Neither experience changes the timing. Appetite effect at 5mg is typically more pronounced, which is why the step up feels significant for most people. Our clinical team at nume reviews every repeat order individually (not as a batch process) and looks specifically at how you reported tolerating the starter dose before supporting a step to 5mg.

One practical check: if you are still managing nausea most days by the time week four arrives, that is worth raising honestly with your prescriber rather than assuming the step up will sort itself out. It may still be the right move, or you may benefit from a little longer at 2.5mg. Either outcome is fine.

When staying at 2.5mg longer is the right call

Stepping up is not always the next move. If gastrointestinal side effects are ongoing and disruptive (daily vomiting, significant diarrhoea, or an inability to eat without discomfort) most prescribers will advise completing more time at the starter dose rather than adding a higher dose on top of an unsettled system. The general guidance on moving up a Mounjaro dose explains this reasoning in more detail across the full titration journey.

There are also situations where a dose increase is paused for reasons unrelated to side effects: planned surgery, illness, pregnancy concerns, or a recent change in other medications. If you use the oral contraceptive pill, it is worth knowing that NHS England's weight-management guidance advises adding a non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide may reduce how well the pill is absorbed. That is a conversation to have with your prescriber before moving up, not after.

For a broader picture of what Mounjaro costs at different stages of treatment, the Mounjaro cost page sets out how private pricing works across the dose range.

How the decision gets made through a regulated service

Self-adjusting your Mounjaro dose is not safe. The dose schedule is licensed for a reason: each step up carries renewed potential for side effects, and your prescriber needs to confirm that the clinical picture supports moving forward. At a regulated pharmacy, every repeat order goes through a prescriber review before it is dispensed. That review is not a formality.

At nume, the process is straightforward. When you request your next supply, a GPhC-registered prescriber reads your consultation answers the same day, a real clinician, not an automated system. They consider your reported tolerance, any changes in your health since the last supply, and whether the evidence supports the step you are requesting. Our guidance on when to up your Mounjaro dose sets out the clinical factors a prescriber weighs before approving a step up, and reflects the same framework our team applies at every review. If it does, the next pen is dispatched same-day for next-working-day delivery. If there is a reason to pause, they will tell you why.

Our FAQs answer common questions about the review process, including when to move from 2.5 to 5 in Mounjaro, and you can reach our clinical team through the support page if something comes up between orders. If you are exploring whether Mounjaro is the right treatment for you in the first place, checking your eligibility is the natural starting point.